BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,130
+180 (1.64%)
Apr 10, 2026, 3:30 PM KST
Market Cap348.73B -34.0%
Revenue (ttm)168.47B +29.5%
Net Income-3.23B
EPS-101.29
Shares Out31.85M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume161,481
Average Volume202,498
Open11,090
Previous Close10,950
Day's Range10,970 - 11,170
52-Week Range10,600 - 21,250
Beta0.91
RSI39.47
Earnings DateMay 15, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 650
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

In 2025, BINEX's revenue was 168.47 billion, an increase of 29.55% compared to the previous year's 130.05 billion. Losses were -3.23 billion, -90.80% less than in 2024.

Financial Statements